Callan Family Office’s L3Harris LHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.78M Sell
8,058
-122
-1% -$42.6K 0.06% 286
2025
Q4
$2.4M Buy
8,180
+2,161
+36% +$625K 0.05% 318
2025
Q3
$1.84M Buy
6,019
+461
+8% +$126K 0.06% 276
2025
Q2
$1.39M Buy
5,558
+2,839
+104% +$652K 0.04% 335
2025
Q1
$569K Sell
2,719
-2,335
-46% -$489K 0.04% 301
2024
Q4
$1.06M Buy
5,054
+2,427
+92% +$582K 0.07% 240
2024
Q3
$625K Buy
2,627
+34
+1% +$7.85K 0.11% 94
2024
Q2
$582K Buy
+2,593
New +$560K 0.11% 77

Other funds holding LHX

Callan Family Office's LHX Position: Q1 2026 in Review

Callan Family Office reduced its L3Harris (LHX) stake by 1.5% in Q1 2026, selling an estimated $42.6K and leaving 8,058 shares worth $2.78M. The position accounts for 0.06% of the portfolio, ranked #286.

Callan Family Office first reported a position in LHX in Q2 2024 and has held it in 8 quarters since. 1,728 funds tracked by Wall St. Rank hold LHX as of Q1 2026.

  • Callan Family Office held 8,058 shares of L3Harris worth $2.78M as of Q1 2026.
  • Callan Family Office sold 122 L3Harris shares in Q1 2026, an estimated $42.6K.
  • L3Harris made up 0.06% of Callan Family Office's portfolio in Q1 2026, its #286 holding.
  • Callan Family Office first reported a position in L3Harris in Q2 2024 and has held it in 8 quarters since.
  • 1,728 funds tracked by Wall St. Rank held L3Harris as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.